| Schedule of Accounts Receivable |
Accounts receivable at June 30, 2019 and December
31, 2018 consisted of the following:
| |
|
June 30, 2019 |
|
|
December 31, 2018 |
|
| Accounts receivable - Clinical Laboratory Operations |
|
$ |
272,369 |
|
|
$ |
622,009 |
|
| Accounts receivable - Hospital Operations |
|
|
40,295,551 |
|
|
|
31,607,644 |
|
| Accounts receivable- Other |
|
|
(14,141 |
) |
|
|
- |
|
| Total accounts receivable |
|
|
40,553,779 |
|
|
|
32,229,653 |
|
| Less: |
|
|
|
|
|
|
|
|
| Amount purchased by factor |
|
|
(1,017,769 |
) |
|
|
- |
|
| Allowance for discounts - Clinical Laboratory Operations |
|
|
(236,898 |
) |
|
|
(573,584 |
) |
| Allowance for discounts - Hospital Operations |
|
|
(31,998,359 |
) |
|
|
(25,066,799 |
) |
| Allowance for bad debts |
|
|
(2,392,159 |
) |
|
|
(2,777,521 |
) |
| Accounts receivable, net |
|
$ |
4,908,594 |
|
|
$ |
3,811,749 |
|
|